<div style="display: flex; align-items: center;">
  <!-- Left side: Profile picture (circle) -->
  <div style="margin-right: 30px;">
    <img src="SB.jpg" alt="Profile Picture" width="150" style="border-radius: 50%;">
  </div>

  <!-- Middle section: Additional text -->
  <div>
    <p>Neuroimmunology Scientist<br>Department of Neurology<br>University Hospital Düsseldorf<br>Heinrich Heine University Düsseldorf</p>
  </div>

  <!-- Right side: Logos for LinkedIn, Google Scholar, GitHub -->
  <div>
    <ul style="list-style: none; padding: 0;">
      <li style="margin-bottom: 8px;"><a href="mailto:barman.sumanta@gmail.com" style="margin-left: 300px;"><img src="Email-logo.png" alt="Email" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://www.linkedin.com/in/dr-sumanta-barman-327954143/" style="margin-left: 300px;"><img src="linkedIn_logo.png" alt="LinkedIn" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://scholar.google.com/citations?user=GUAu_j0AAAAJ&hl=en" style="margin-left: 300px;"><img src="google_scholar_logo.png" alt="Google Scholar" width="30"></a></li>
      <li style="margin-bottom: 8px;"><a href="https://github.com/sumanta-barman" style="margin-left: 300px;"><img src="github-logo.png" alt="GitHub" width="30"></a></li>
    </ul>
  </div>
</div>

---

  
<!-- Middle section: Main Content -->
  <div style="flex: 1;">
    <div style="text-align: justify;">
    <!-- Anchor links and section headings (Table of Contents) -->
    <div style="position: sticky; top: 0; left: 0; right: 0; width: 100%; background-color: #fff; z-index: 1; padding: 10px;">
      <ul style="list-style: none; padding-left: 0;">
        <a href="#biography" style="margin-right: 10px;">Biography</a> |
        <a href="#about-me" style="margin-right: 10px;">About Me</a> |
        <a href="#expertise" style="margin-right: 10px;">Expertise</a> |
        <a href="#research-highlights" style="margin-right: 10px;">Research Highlights</a> |
        <a href="#tools-technologies" style="margin-right: 10px;">Tools and Technologies</a> |
        <a href="#professional-experience" style="margin-right: 10px;">Professional Experience</a> |
        <a href="#education" style="margin-right: 10px;">Education</a> |
        <a href="#research-articles" style="margin-right: 10px;">Research Articles</a> |
        <a href="#complete-list-of-publications" style="margin-right: 10px;">Complete List of Publications</a> |
        <a href="#contact-me">Contact Me</a>
      </ul>
    </div>
    </div>
  </div>
  
    
  
    
---

<!-- Main content area with scrolling text -->
<div style="padding-top: 10px;">
</div>


---
## Biography
  
<div style="text-align: justify;">
      Sumanta Barman is an neuroimmunology scientist, specialized in computational immulogy at the department of Neurology, University Hospital Düsseldorf. He is involved in analysing single cell multiomics, next generation sequencing and bioinformatics data, investigating treatment effects of immunotherapies on patients’ immune repertoire, as well as the development and characterization of recombinant human monoclonal antibodiesRecombinant antibody technology.
</div>

## About Me

<div style="text-align: justify;">

I am a research scientist specializing in Central Nervous System (CNS) autoimmune diseases with expertise in immunology, molecular biology, immunogenomics, transcriptomics, proteomics and bioinformatics. My work focuses on analyzing human immune repertoires using next-generation sequencing (NGS) and exploring the potential of AI in precision medicine. As a highly skilled research scientist with a focus on Central nervous system (CNS) autoimmune diseases, I possess extensive expertise in various aspects of human immune repertoire (IR) analysis, "-omics" technologies, especially immunogenomics/transcriptomics, single B cell recombinant antibody technology, and bioinformatics. My expertise in next-generation sequencing (NGS), both in laboratory and computational, as well as my proficiency in bulk and single cell RNA-Seq data analysis (IR & Transcriptomics), quantitative PCR, flow cytometry, affinity chromatography, cell culture, and more, allow me to extract valuable insights and drive progress in the field of neuroimmunology. My mastery of data analysis using Python and R, alongside machine learning and deep learning-based tools, empowers me to make informed decisions based on data and evidence. In addition, I possess good knowledge of statistical approaches, utilizing tools such as R, SPSS and GraphPad Prism, to derive meaningful insights and statistical interpretations in research. Furthermore, I am deeply enthusiastic about the application of artificial intelligence (AI) in healthcare and its potential to revolutionize precision medicine.

  
My dedication and perseverance have resulted in numerous scientific publications and presentations, both oral and poster, at international conferences. Additionally, I have had the opportunity to mentor multi-cultural students in all aspects of research, including project conception, methodology, data analysis, presentation, and report writing for bachelor's, master's, and PhD theses.

  
I have extensive expertise in evaluating the treatment effect of various disease-modifying therapies, including Alemtuzumab (Lemtrada) from Sanofi-Genzyme, Fingolimod (Gilenya) from Novartis, and Ocrelizumab (Ocrevus) from Roche, on the peripheral immune repertoire of multiple sclerosis patients. I also have experience in the development of recombinant human monoclonal antibodies from clonally expanded plasma cells (cePc) of patients with autoimmune and viral encephalitis. In addition, I have a comprehensive understanding of multi-omics technologies, as well as proficiency in R, Python, deep learning, and machine learning-based biological data analysis.

</div>

---

## Expertise

- **Next generation sequencing library preparation**
- **Immunogenomics/Transcriptomics/Proteomics data analysis**
- **Single B Cell Recombinant Antibodies**
- **Bioinformatics**
- **Bulk and Single Cell RNA-Seq Analysis**
- **Quantitative PCR**
- **Flow Cytometry**
- **Affinity Chromatography**
- **Cell Culture**
- **Statistical Analysis using R, SPSS, GraphPad Prism**
- **Machine Learning and Deep Learning**
- **Multi-omics Technologies**

---

## Research Highlights

- Investigating treatment effects of disease-modifying therapies in multiple sclerosis patients
- Development of recombinant human monoclonal antibodies for autoimmune and viral encephalitis
- Mentoring students in research methodology and data analysis
- Contributed to scientific publications and presentations at international conferences

---

## Tools & Technologies

- **Programming:** Python, R
- **Data Analysis:** Pandas, NumPy, SciPy, Seurat, Scanpy, Scvitolls
- **Machine Learning:** Scikit-learn, TensorFlow, PyTorch
- **Bioinformatics:** BWA, SAMtools, Bioconductor
- **Statistical Analysis:** RStudio, SPSS, GraphPad Prism

---

##Professional Experience

---

##Education

---

##Research Articals

<strong>Selected Publications<strong>

*Computational immunology:*

1. **[Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity](https://academic.oup.com/brain/article/145/5/1711/6590581)**  
   *Authors:* Tobias Ruck#, <strong>Sumanta Barman#</strong>, Andreas Schulte-Mecklenbeck#, Steffen Pfeuffer#, Falk Steffen, Christopher Nelke, Christina B Schroeter, Alice Willison, Michael Heming, Thomas Müntefering, Nico Melzer, Julia Krämer, Maren Lindner, Marianne Riepenhausen, Catharina C Gross, Luisa Klotz, Stefan Bittner, Paolo A Muraro, Tilman Schneider-Hohendorf, Nicholas Schwab, Gerd Meyer zu Hörste, Norbert Goebels, Sven G Meuth, Heinz Wiendl. *<strong>#equally contributing first authors</strong>*
   
   *Journal:* Brain  
   *Year:* 2022

    <a href="https://academic.oup.com/brain/article/145/5/1711/6590581"><img src="awac064f4.jpeg" alt="Thumbnail" width="200"></a>

2. **[Classifying flow cytometry data using Bayesian analysis helps to distinguish ALS patients from healthy controls](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1198860/full)**  
   *Authors:* Saskia Räuber, Christopher Nelke, Christina B Schroeter,  <strong>Sumanta Barman</strong>, Marc Pawlitzki, Jens Ingwersen, Katja Akgün, Rene Günther, Alejandra P Garza, Michaela Marggraf, Ildiko Rita Dunay, Stefanie Schreiber, Stefan Vielhaber, Tjalf Ziemssen, Nico Melzer, Tobias Ruck, Sven G Meuth, Michael Herty.
   
   *Journal:* Frontiers in Immunology  
   *Year:* 2023
   
   <a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1198860/full"><img src="https://www.frontiersin.org/files/Articles/1198860/fimmu-14-1198860-HTML/image_m/fimmu-14-1198860-g004.jpg" alt="Thumbnail" width="300"></a>

3. **T cell specificity and protective functions elicited by KSHV infection of B cells in vivo**  
   *Authors:* Nicole Caduff, Lisa Rieble1, Michelle Böni, Donal McHugh, Romin Roshan, Wendell Miley, Nazzarena Labo, <strong>Sumanta Barman</strong>, Matthew Trivett, Douwe M. T. Bosma, Julia Rühl, Norbert Goebels, Denise Whitby, Christian Münz.

   *Journal:* Nature communications (Accepted)  
   *Year:* 2024

4. **Consensus clustering identifies disease subtypes of myasthenia gravis**  
   *Authors:* Christopher Nelke, Christina B. Schroeter, <strong>Sumanta Barman</strong>, Frauke Stascheit, Lars Masanneck, Lukas Theissen, Niklas Huntemann, Derya Cengiz, Vera Dobelmann, Marc Pawlitzki, Saskia Räuber, Hans-Peter Hartung, Simone König, Andreas Roos, Andreas Meisel, Sven G. Meuth, Tobias Ruck.
   
   *Under review* 
   
5. **Dynamic reshaping of lymphocyte repertoires in multiple sclerosis patients treated with Alemtuzumab: Insights into secondary autoimmunity**  
   *Authors:* <strong>Sumanta Barman et al.</strong>
   
   *Ready to submit*   

6. **Anti GAD encephalitis**  
   *Authors:* <strong>Sumanta Barman et al.</strong>
   
   *On preparation*   

    
*Neuroimmunology:*

1. **[NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody](https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.444)**  
   *Authors:* Manish Malviya#, <strong>Sumanta Barman#</strong>, Kristin S Golombeck#, Jesús Planagumà#, Francesco Mannara#, Nathalie Strutz‐Seebohm, Claudia Wrzos, Fatih Demir, Christine Baksmeier, Julia Steckel, Kim Kristin Falk, Catharina C Gross, Stjepana Kovac, Kathrin Bönte, Andreas Johnen, Klaus‐Peter Wandinger, Elena Martín‐García, Albert J Becker, Christian E Elger, Nikolaj Klöcker, Heinz Wiendl, Sven G Meuth, Hans‐Peter Hartung, Guiscard Seebohm, Frank Leypoldt, Rafael Maldonado, Christine Stadelmann, Josep Dalmau, Nico Melzer, Norbert Goebels. *<strong>#equally contributing first authors</strong>*
   
   *Journal:* Annals of clinical and translational neurology  
   *Year:* 2017
   
   <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.444"><img src="https://onlinelibrary.wiley.com/cms/asset/20fe6556-ba39-4887-9dbb-0d067072d452/acn3444-fig-0004-m.jpg" alt="Thumbnail" width="200"></a>

   
2. **[Myelinating Co-Culture as a Model to Study Anti-NMDAR Neurotoxicity](https://www.mdpi.com/1422-0067/24/1/248)**  
   *Authors:* Mercedeh Farhat Sabet, <strong>Sumanta Barman</strong>, Mathias Beller, Sven G Meuth, Nico Melzer, Orhan Aktas, Norbert Goebels, Tim Prozorovski.
   
   *Journal:* International Journal of Molecular Sciences  
   *Year:* 2023
   
   <a href="https://www.mdpi.com/1422-0067/24/1/248"><img src="https://www.mdpi.com/ijms/ijms-24-00248/article_deploy/html/images/ijms-24-00248-g001.png" alt="Thumbnail" width="200"></a>

3. **[An assay to determine mechanisms of rapid autoantibody-induced neurotransmitter receptor endocytosis and vesicular trafficking in autoimmune encephalitis](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2019.00178/full)**  
   *Authors:* Elsie Amedonu, Christoph Brenker, <strong>Sumanta Barman</strong>, Julian A Schreiber, Sebastian Becker, Stefan Peischard, Nathalie Strutz-Seebohm, Christine Strippel, Andre Dik, Hans-Peter Hartung, Thomas Budde, Heinz Wiendl, Timo Strünker, Bernhard Wünsch, Norbert Goebels, Sven G Meuth, Guiscard Seebohm, Nico Melzer
   
   *Journal:* Frontiers in Neurology  
   *Year:* 2019
   
   <a src="https://www.frontiersin.org/files/Articles/425928/fneur-10-00178-HTML/image_m/fneur-10-00178-g003.jpg" alt="Thumbnail" width="300"></a>

4. **[Dose‐dependent inhibition of demyelination and microglia activation by IVIG](https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.326)**  
   *Authors:* Meike Winter, Christine Baksmeier, Julia Steckel, <strong>Sumanta Barman</strong>, Manish Malviya, Melanie Harrer‐Kuster, Hans‐Peter Hartung, Norbert Goebels
   
   *Journal:* Annals of clinical and translational neurology  
   *Year:* 2016
   
   <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.326"><img src="https://onlinelibrary.wiley.com/cms/asset/9b8bfd67-5778-4e1e-b7d5-aac0a7ec3b06/acn3326-fig-0002-m.jpg" alt="Thumbnail" width="200"></a>
   
5. **[N‐methyl‐D‐aspartate receptor antibodies in autoimmune encephalopathy alter oligodendrocyte function](https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25699)**  
   *Authors:* Carlos Matute, Ana Palma, María Paz Serrano‐Regal, Estibaliz Maudes, <strong>Sumanta Barman</strong>, María Victoria Sánchez‐Gómez, María Domercq, Norbert Goebels, Josep Dalmau. 
   
   *Journal:* Annals of neurology  
   *Year:* 2020
   
   <a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ana.25699"><img src="ana25699-fig-0001-m.png" alt="Thumbnail" width="200"></a>


*Conference publications:*

1. **ddddd**
2. **hhhh**

*Others:*

1. **jjj**
2. **ggg**

   
---

## Complete List of Publications

- You can also find a complete list of my publications [here](https://scholar.google.com/citations?user=GUAu_j0AAAAJ&hl=en).

---

## Contact Me

<a href="mailto:barman.sumanta@gmail.com"><img src="Email-logo.png" alt="Email" width="30"></a>

---

Feel free to reach out if you are interested in collaboration or have any inquiries related to my research!
  


